@article{e0c08bbf4f7d46ac83403c9de0a025cb,
title = "The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.",
abstract = " The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.",
keywords = "Hyperbaric Oxygen, Jaw, Management, Osteoradionecrosis, Prevention",
author = "Alessandro Villa and A. Sultan and Hanna, \{G. L.\} and D.N. Margalit and N. Chau and Goguen, \{L. A.\} and Marty, \{F. M.\} and G. Rabinowits and Shoenfeld, \{J. D.\} and Sonis, \{S. T.\} and T. Thomas and Tishler, \{R. B.\} and Treister, \{N. S.\} and Woo, \{S. B\} and R. Haddad and H. Mawardi",
note = "Based on the available evidence and expert opinion, routine use of HBO for the prevention or management of ORN is not recommended and is rarely used at our institution. The Oncologist 2017;22:343-350 IMPLICATIONS FOR PRACTICE: The Division of Head and Neck Oncology of Dana-Farber/Brigh ...",
year = "2017",
month = mar,
doi = "10.1634/theoncologist.2016-0298",
language = "American English",
volume = "22",
journal = "Oncologist",
}